Articles from Inogen, Inc.

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Mira Kirti Sahney to Inogen’s Board of Directors, effective January 31, 2025. The company also announced that Tom West, who has served as a director since April 2023, retired as a member of the Board of Directors, effective January 30, 2025.
By Inogen, Inc. · Via Business Wire · February 3, 2025

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced it has entered into a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ, “Yuwell”), a global home healthcare medical device manufacturer with a comprehensive portfolio of respiratory products.
By Inogen, Inc. · Via Business Wire · January 26, 2025

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced unaudited preliminary revenue results for the fourth quarter and the full year ended December 31, 2024.
By Inogen, Inc. · Via Business Wire · January 13, 2025

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SIMEOX 200 Airway Clearance Device, expanding the company’s ability to market and meet the various needs of patients with chronic respiratory diseases in the U.S.
By Inogen, Inc. · Via Business Wire · December 30, 2024

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended September 30, 2024.
By Inogen, Inc. · Via Business Wire · November 7, 2024

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor conferences:
By Inogen, Inc. · Via Business Wire · November 4, 2024

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report third quarter 2024 financial results after the market closes on Thursday, November 7, 2024. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET.
By Inogen, Inc. · Via Business Wire · October 17, 2024

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has commenced the U.S. market release of the Inogen® Rove 4™ Portable Oxygen Concentrator.
By Inogen, Inc. · Via Business Wire · October 8, 2024

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Eric Pauls as Vice President of Sales, North America, effective September 3, 2024. Mr. Pauls joins Inogen from RQM+, where he served as Chief Customer Officer.
By Inogen, Inc. · Via Business Wire · September 5, 2024

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended June 30, 2024.
By Inogen, Inc. · Via Business Wire · August 6, 2024

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2024 financial results after the market closes on Tuesday, August 6, 2024. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET.
By Inogen, Inc. · Via Business Wire · July 16, 2024

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith joins Inogen from Sirtex Medical, where he served as General Counsel and Executive Vice President, Business Development, since 2018.
By Inogen, Inc. · Via Business Wire · July 3, 2024

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today shared the results of a study published in the journal Pulmonary Therapy, demonstrating the association of portable oxygen concentrators with increased survival and cost-effectiveness ratio when compared to other long-term oxygen therapies.
By Inogen, Inc. · Via Business Wire · June 3, 2024

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended March 31, 2024.
By Inogen, Inc. · Via Business Wire · May 7, 2024

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2024 financial results after the market closes on Tuesday, May 7, 2024. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET.
By Inogen, Inc. · Via Business Wire · April 10, 2024

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced management will participate in the 23rd Annual Needham Virtual Healthcare Conference.
By Inogen, Inc. · Via Business Wire · March 25, 2024

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that, effective March 4, 2024, the Compensation Committee of Inogen’s Board of Directors approved awards of restricted stock units as material inducement to Michael Bourque entering into employment with the company to serve as its Executive Vice President, Chief Financial Officer and Treasurer. The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan.
By Inogen, Inc. · Via Business Wire · March 7, 2024

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the full-year ended December 31, 2023.
By Inogen, Inc. · Via Business Wire · February 27, 2024

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report fourth quarter and full year 2023 financial results after the market closes on Tuesday, February 27, 2024. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET.
By Inogen, Inc. · Via Business Wire · January 30, 2024

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Michael Bourque as Chief Financial Officer, effective March 4, 2024. Mr. Bourque has served as Treasurer and Chief Financial Officer of Chase Corporation (formally NYSE:CCF) now owned by KKR & Co. Inc. He succeeds Interim Chief Financial Officer Mike Sergesketter, who will remain in an advisory role during the transition.
By Inogen, Inc. · Via Business Wire · January 24, 2024

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of Directors has appointed Kevin Smith as Inogen’s President and Chief Executive Officer and a member of the Board of Directors, effective immediately, succeeding Nabil Shabshab.
By Inogen, Inc. · Via Business Wire · November 13, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor conferences:
By Inogen, Inc. · Via Business Wire · November 9, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended September 30, 2023.
By Inogen, Inc. · Via Business Wire · November 7, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report third quarter 2023 financial results after the market closes on Tuesday, November 7, 2023. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET.
By Inogen, Inc. · Via Business Wire · October 10, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced it has completed the acquisition of Physio-Assist SAS, expanding the company’s innovative respiratory portfolio.
By Inogen, Inc. · Via Business Wire · September 18, 2023

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Mike Sergesketter as Interim Chief Financial Officer, effective immediately. Mr. Sergesketter last served as Interim Chief Financial Officer of the company between December 2021 and March 2022, and previously served as CFO of Kimball Electronics, Inc. where he was instrumental in helping to develop and execute the company’s globalization strategy while also building a robust finance function to support the company’s growth. He succeeds Kristin Caltrider who has stepped down for personal reasons. Ms. Caltrider’s decision was not related to any disagreements with the Company or its management on any matters relating to the Company’s operations, policies, or practices. The Company has retained a leading executive search firm to help with the search for a permanent replacement.
By Inogen, Inc. · Via Business Wire · September 7, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that it has been selected as a finalist in the Diversity, Equity & Inclusion Commitment Category for Ragan's CSR & Diversity Awards Program. This recognition celebrates the outstanding efforts of organizations that have demonstrated exemplary commitment to corporate social responsibility and fostering diversity and inclusion within their communities and workplaces.
By Inogen, Inc. · Via Business Wire · August 8, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended June 30, 2023.
By Inogen, Inc. · Via Business Wire · August 7, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the introduction of the Rove 6™ portable oxygen concentrator in the United States with best in class 8-year expected service life.
By Inogen, Inc. · Via Business Wire · August 7, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the company has entered into a definitive agreement to purchase Physio-Assist SAS, a privately-held company headquartered in France.
By Inogen, Inc. · Via Business Wire · July 13, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will participate in the William Blair 43rd Annual Growth Stock Conference.
By Inogen, Inc. · Via Business Wire · May 15, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended March 31, 2023.
By Inogen, Inc. · Via Business Wire · May 4, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2023 financial results after the market closes on Thursday, May 4, 2023. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET.
By Inogen, Inc. · Via Business Wire · April 6, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will participate in a virtual fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on Wednesday, April 19, 2023 at 12:45 p.m. Eastern Time.
By Inogen, Inc. · Via Business Wire · April 4, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Tom West to Inogen’s Board of Directors, effective April 1, 2023. The company also announced that Kristen Miranda, who has served as a director since March 2021, will retire as a member of the Board of Directors, effective March 31, 2023.
By Inogen, Inc. · Via Business Wire · March 22, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will participate in a virtual fireside chat at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023 at 2:15 p.m. Eastern Time.
By Inogen, Inc. · Via Business Wire · March 8, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will host a conference call on Monday, February 27, 2023, at 10:00 a.m. Eastern Time. At the event, Nabil Shabshab, President and Chief Executive Officer, and Kristin Caltrider, Chief Financial Officer, will provide an update on the Company’s commercial and innovation strategies.
By Inogen, Inc. · Via Business Wire · February 23, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the full year ended December 31, 2022.
By Inogen, Inc. · Via Business Wire · February 23, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has achieved regulatory milestones in the EU and the US to support its portable oxygen concentrator products.
By Inogen, Inc. · Via Business Wire · January 10, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced unaudited preliminary revenue results for the fourth quarter and the full year ended December 31, 2022.
By Inogen, Inc. · Via Business Wire · January 10, 2023

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference.
By Inogen, Inc. · Via Business Wire · December 13, 2022

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor conferences:
By Inogen, Inc. · Via Business Wire · November 3, 2022

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended September 30, 2022, and provided a business update.
By Inogen, Inc. · Via Business Wire · November 2, 2022

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will issue third quarter 2022 financial results before the market opens on Wednesday, November 2, 2022. On the same day, the Company will host a conference call beginning at 5:30 am PT / 8:30 am ET.
By Inogen, Inc. · Via Business Wire · October 5, 2022

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended June 30, 2022 and provided a business update.
By Inogen, Inc. · Via Business Wire · August 4, 2022

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2022 financial results after market close on Thursday, August 4, 2022. The Company will host a corresponding conference call beginning at 2:00 pm PT/5:00 pm ET.
By Inogen, Inc. · Via Business Wire · July 7, 2022

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Agnes Lee to the position of Senior Vice President of Investor Relations and Strategic Planning, effective May 23, 2022.
By Inogen, Inc. · Via Business Wire · May 18, 2022

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three months ended March 31, 2022.
By Inogen, Inc. · Via Business Wire · May 5, 2022

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2022 financial results after market close on Thursday, May 5, 2022. The Company will host a corresponding conference call beginning at 2:00pm PT/5:00pm ET.
By Inogen, Inc. · Via Business Wire · April 14, 2022

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 21st Annual Needham Virtual Healthcare Conference.
By Inogen, Inc. · Via Business Wire · March 30, 2022

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Glenn Boehnlein, Kevin King, and Mary Katherine Ladone to Inogen’s Board of Directors, effective March 22, 2022. In conjunction with these appointments, Heath Lukatch (director since 2006), Benjamin Anderson-Ray (director since 2013), and Loren McFarland (director since 2013) retired from the Board.
By Inogen, Inc. · Via Business Wire · March 23, 2022

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three- and twelve-month periods ended December 31, 2021.
By Inogen, Inc. · Via Business Wire · February 24, 2022

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release fourth quarter 2021 financial results after market close on Thursday, February 24, 2022. The Company will host a corresponding conference call beginning at 2:00pm PT/5:00pm ET.
By Inogen, Inc. · Via Business Wire · January 26, 2022

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported preliminary, unaudited revenue results for the three-month and twelve-month periods ended December 31, 2021.
By Inogen, Inc. · Via Business Wire · January 10, 2022

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Elizabeth (Beth) Mora was elected as Board Chairperson. Ms. Mora has served as a member of Inogen’s Board of Directors since May 24, 2021, and is also a member of the Audit and Compliance Committees. She assumes the role from Heath Lukatch, Ph.D., who has served as Chairperson of the Board since 2008. Dr. Lukatch will remain on the Board as a director and member of the Compensation Committee.
By Inogen, Inc. · Via Business Wire · December 30, 2021

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s presentation at the 40th Annual J.P. Morgan Healthcare Conference has been moved due to the conference moving into a virtual format.
By Inogen, Inc. · Via Business Wire · December 16, 2021

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 40th Annual J.P. Morgan Healthcare Conference.
By Inogen, Inc. · Via Business Wire · December 15, 2021

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Mike Sergesketter as Interim Chief Financial Officer, effective immediately. Mr. Sergesketter most recently served as CFO of Kimball Electronics, Inc. where he was instrumental in helping to develop and execute the company’s globalization strategy while also building a robust finance function designed to support the company’s growth. He succeeds Alison Bauerlein who will be staying with the Company in a transitional finance role through the first quarter of 2022. The Company has retained a leading executive search firm to help with the search for a permanent replacement.
By Inogen, Inc. · Via Business Wire · December 13, 2021

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three months ended September 30, 2021.
By Inogen, Inc. · Via Business Wire · November 4, 2021

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in Stifel Virtual Healthcare Conference.
By Inogen, Inc. · Via Business Wire · November 2, 2021

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2021 financial results after market close on Thursday, November 4, 2021. The Company will host a corresponding conference call beginning at 2:00pm PT/5:00pm ET.
By Inogen, Inc. · Via Business Wire · October 13, 2021

Inogen, Inc. (NASDAQINGN), (“Inogen” or “the Company”), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that Stanislav Glezer, MD has been appointed to the role of Chief Technology Officer responsible for R&D and Engineering, Medical Affairs, and Regulatory Affairs. Mr. Glezer will remain an Executive Vice President of the Company.
By Inogen, Inc. · Via Business Wire · October 12, 2021

Inogen, Inc. (NASDAQINGN), (“Inogen” or “the Company”), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced an agreement to enhance its go-to-market capabilities with Ashfield Healthcare, LLC, part of UDG Healthcare (“Ashfield”).
By Inogen, Inc. · Via Business Wire · September 21, 2021

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three months ended June 30, 2021.
By Inogen, Inc. · Via Business Wire · August 4, 2021

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2021 financial results after market close on Wednesday, August 4, 2021. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.
By Inogen, Inc. · Via Business Wire · July 14, 2021

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed Jason Somer as Inogen’s Executive Vice President and General Counsel and Secretary, effective July 12, 2021.
By Inogen, Inc. · Via Business Wire · June 21, 2021

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed Dr. Stanislav Glezer as Inogen’s Executive Vice President and Chief Medical Officer, effective June 21, 2021.
By Inogen, Inc. · Via Business Wire · June 8, 2021

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Elizabeth (Beth) Mora has been appointed to its Board of Directors, effective May 24, 2021. In addition, Ms. Mora was appointed as a member of the Board’s Audit Committee. She will serve as a Class I director, with a term expiring at the annual meeting of stockholders to be held in 2024. Ms. Mora fills the vacancy on the Board and the Board’s Audit Committee created by the resignation of R. Scott Greer, who resigned effective May 24, 2021. Mr. Greer had served as a member of Inogen’s Board since 2015. In connection with this transition, Mr. Loren McFarland, an existing member of the Audit Committee, was appointed as Chairperson of the Board’s Audit Committee and Ms. Mora was appointed as a member of the Board’s Audit Committee, in each case effective May 24, 2021.
By Inogen, Inc. · Via Business Wire · May 24, 2021

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 41st Annual William Blair Virtual Growth Stock Conference.
By Inogen, Inc. · Via Business Wire · May 12, 2021

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three months ended March 31, 2021.
By Inogen, Inc. · Via Business Wire · May 4, 2021

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2021 financial results after market close on Tuesday, May 4th, 2021. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.
By Inogen, Inc. · Via Business Wire · April 19, 2021

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed George Parr as Inogen’s Executive Vice President and Chief Commercial Officer, effective April 12, 2021. On April 2, 2021 and April 5, 2021, respectively, Byron Myers, Executive Vice President, Marketing, and Arron Retterer, Executive Vice President, Sales, announced that they plan to leave Inogen effective June 4, 2021 following a transition period to help ensure an orderly and effective shift of responsibilities.
By Inogen, Inc. · Via Business Wire · April 7, 2021

Inogen, Inc. (NASDAQINGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 20th Annual Needham Virtual Healthcare Conference.
By Inogen, Inc. · Via Business Wire · April 6, 2021